Recent Finacing
Recent Raise
Semarion develops SemaCyte, a cell-based screening platform that converts adherent cells into barcoded, assay-ready, automation-compatible reagents for drug discovery.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Semarion.
